Actuate Therapeutics Inc.

11/18/2026 | Press release | Distributed by Public on 11/18/2026 07:21

2026-ENA- Evaluation of antitumor activity of oral elraglusib in B16F10 melanoma model

Actuate Therapeutics Inc. published this content on November 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 18, 2026 at 13:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]